ACTRN12612000101886已完成1 期
A Randomized controled trial of Famotidine as a Radioprotector agent versus Placebo before External Beam Radiotherapy in Patients with Prostate Cancer to Reduce Radiation- induced Acute Bowel & Urinary Toxicity using RTOG Criteria
School of Paramedical Sciences, Shahid Beheshti Medical University,0 个研究点目标入组 36 人开始时间: 2012年1月20日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- o limit 至 o limit（—）
- 性别
- Male
入选标准
- •Patients with Prostate Cancer Candidate for External Beam Radiotherapy
排除标准
- •Patients with Metastatic Prostate Cancer, Patients with Kidney & Liver dysfunction, Patients who receive any H2– Histamine receptor antagonist simultaneously, Patients with Allergic reaction in consequence of Famotidine Administration.
研究者
相似试验
招募中
3 期
The effect of famotidine on reducing the side effects of prostate cancer radiotherapyIRCT20231121060132N1Kermanshah University of Medical Sciences50
已完成
3 期
Clinical trial on the effectiveness of the Famotidine on symptoms of schizophrenic patientsSchizophreniaIRCT20190707044123N1Rasht University of Medical Sciences64
招募中
Unknown
Bioequivalence study of Famotidine SuspensioIn the present study, the products will be administered to healthy volunteers.IRCT20210519051345N44Tabriz University of Medical Sciences24
进行中（未招募）
2 期
Famotidine vs Placebo for the Treatment of Non-Hospitalized Adults With COVID-19Covid-19NCT04724720Northwell Health56
进行中（未招募）
1 期
A study to test whether lasmiditan is safe and effective in the treatment of migraine with or without aura over four attacksMigraineEUCTR2018-001661-17-ESilly S.A.1,471